Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon

Published:2018-10-19 Issue:11 Volume:27 Page:931-939
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Guda Anisha¹,Feldman Steven R.²^ORCID,Strowd Lindsay³

Affiliation:

1. UT Health San Antonio Long School of Medicine, San Antonio, TX, USA

2. Departments of Dermatology, Pathology and Department of Social Sciences & Health Policy Wake Forest School of Medicine, Center for Dermatology Research, Winston-Salem

3. Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2018.1533550

Reference31 articles.

1. Psoriasis

2. Cytokines in psoriasis

3. Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines

4. Skin immune sentinels in health and disease

5. Psoriasis treatment: current and emerging directed therapies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitors in chronic plaque psoriasis: What is known so far;Drugs of Today;2020

2. Biologics in dermatology: What does the future hold?;Dermatologic Therapy;2019-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP